Literature DB >> 17362806

Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression.

Darin D Dougherty1, Scott L Rauch.   

Abstract

Although neutral-state functional neuroimaging studies have improved the understanding of the pathophysiology of major depression, studies that employ state manipulations may provide further information. Such interventions of the effects of acute or chronic pharmacologic treatment. This article has reviewed issues surrounding functional neuroimaging studies of treatment. Because the ultimate goal of psychiatric research is improved understanding of the pathophysiology as well as treatment of mental illness, the proposed contribution of these studies is the development of tests that will guide case management and thus be clinically useful.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362806     DOI: 10.1016/j.psc.2006.12.007

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  17 in total

Review 1.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

2.  Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months.

Authors:  Aaron S Heller; Tom Johnstone; Michael J Peterson; Gregory G Kolden; Ned H Kalin; Richard J Davidson
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

Review 3.  Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature.

Authors:  Eduardo Caverzasi; Anna Pichiecchio; Guy Umberto Poloni; Alessandro Calligaro; Moreno Pasin; Fulvia Palesi; Gloria Castellazzi; Massimo Pasquini; Massimo Biondi; Francesco Barale; Stefano Bastianello
Journal:  Funct Neurol       Date:  2012 Jan-Mar

4.  Functional connectivity between ventral prefrontal cortex and amygdala at low frequency in the resting state in bipolar disorder.

Authors:  Lara G Chepenik; Mariella Raffo; Michelle Hampson; Cheryl Lacadie; Fei Wang; Monique M Jones; Brian Pittman; Pawel Skudlarski; Hilary P Blumberg
Journal:  Psychiatry Res       Date:  2010-05-20       Impact factor: 3.222

5.  Standardization and validation of a parallel form of the verbal and non-verbal recognition memory test in an Italian population sample.

Authors:  Daniela Smirni; Pietro Smirni; Giovanni Di Martino; Lisa Cipolotti; Massimiliano Oliveri; Patrizia Turriziani
Journal:  Neurol Sci       Date:  2018-05-04       Impact factor: 3.307

6.  Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP.

Authors:  Justin T Gass; M Foster Olive
Journal:  Eur J Pharmacol       Date:  2008-02-20       Impact factor: 4.432

Review 7.  The diagnosis and treatment of individuals with mental illness and developmental disabilities: an overview.

Authors:  L Jarrett Barnhill
Journal:  Psychiatr Q       Date:  2008-09-03

8.  Working-memory fMRI reveals cingulate hyperactivation in euthymic major depression.

Authors:  Sonja Schöning; Pienie Zwitserlood; Almut Engelien; Andreas Behnken; Harald Kugel; Hagen Schiffbauer; Katharina Lipina; Christine Pachur; Anette Kersting; Udo Dannlowski; Bernhard T Baune; Peter Zwanzger; Thomas Reker; Walter Heindel; Volker Arolt; Carsten Konrad
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

9.  Does physical anhedonia play a role in depression? A 20-year longitudinal study.

Authors:  Stewart A Shankman; Brady D Nelson; Martin Harrow; Robert Faull
Journal:  J Affect Disord       Date:  2010-01       Impact factor: 4.839

10.  A tractography analysis of two deep brain stimulation white matter targets for depression.

Authors:  David A Gutman; Paul E Holtzheimer; Timothy E J Behrens; Heidi Johansen-Berg; Helen S Mayberg
Journal:  Biol Psychiatry       Date:  2008-11-14       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.